Institutional Review Board Statement
DISEASE
The study was conducted according to the guidelines of the Declaration of Helsinki, approved by the Institutional Review Board of Global Medical Research Center (Protocol No.: GMRC-22415-HK, 29 April 2022) for studies involving humans. The study was registered with registered with the Clinical Research Information Service (CRIS, no. KCT0008242) in the Korea Disease Control and Prevention Agency supported by the Ministry of Health and Welfare.